CXCL8 and neoplasm: The tumor-mediated overexpression and secretion of the chemokine IL-8 (CXCL8) have been utilized as leverage to maximize the tumoricidal effects of CAR-Ts in solid tumors by increasing the intratumoral trafficking of these cells (84).